IRIS
ROSIELLO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.034
NA - Nord America 1.750
AS - Asia 1.680
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 49
Totale 6.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.660
RU - Federazione Russa 1.248
SG - Singapore 621
CN - Cina 478
BR - Brasile 321
SE - Svezia 224
HK - Hong Kong 202
VN - Vietnam 176
IT - Italia 159
DE - Germania 95
FR - Francia 88
GB - Regno Unito 59
BD - Bangladesh 54
IN - India 52
FI - Finlandia 48
CA - Canada 43
AR - Argentina 40
NL - Olanda 28
MX - Messico 27
PL - Polonia 25
ID - Indonesia 19
ZA - Sudafrica 19
EC - Ecuador 18
IQ - Iraq 15
JP - Giappone 14
PE - Perù 12
CO - Colombia 10
AT - Austria 9
ES - Italia 9
LT - Lituania 9
VE - Venezuela 9
MY - Malesia 8
IE - Irlanda 7
MA - Marocco 7
TR - Turchia 7
UZ - Uzbekistan 7
TN - Tunisia 6
UA - Ucraina 6
EG - Egitto 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BO - Bolivia 4
CL - Cile 4
CR - Costa Rica 4
HN - Honduras 4
NP - Nepal 4
BG - Bulgaria 3
GT - Guatemala 3
KE - Kenya 3
MD - Moldavia 3
PY - Paraguay 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JO - Giordania 2
PH - Filippine 2
RO - Romania 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UG - Uganda 1
Totale 5.935
Salva come PNG Salva come JPEG
Città #
Singapore 327
Ashburn 218
Moscow 212
Hong Kong 199
Dallas 182
San Jose 149
Council Bluffs 115
Shanghai 102
New York 90
Hefei 68
Ho Chi Minh City 67
Beijing 59
Los Angeles 59
Lauterbourg 56
Boardman 50
Lawrence 50
Princeton 50
Milan 41
Munich 35
Santa Clara 35
Hanoi 32
Helsinki 26
São Paulo 26
Denver 21
Warsaw 20
Phoenix 19
Turku 19
Orem 18
Atlanta 17
Brooklyn 17
Frankfurt am Main 17
Montreal 17
Manchester 16
Rome 16
Chicago 15
Houston 15
Johannesburg 15
Chennai 13
Haiphong 13
Mexico City 13
Rio de Janeiro 13
Guangzhou 12
Poplar 11
Tokyo 11
Lima 10
Mumbai 10
Toronto 10
Columbus 9
San Francisco 9
Amsterdam 8
Bar Harbor 8
Nuremberg 8
Quito 8
Shenzhen 8
Belo Horizonte 7
Brasília 7
Da Nang 7
Falkenstein 7
Hyderabad 7
The Dalles 7
Washington 7
Barnet 6
Biên Hòa 6
Bologna 6
Dhaka 6
Dronten 6
Dublin 6
London 6
Manaus 6
Seattle 6
Stockholm 6
Tashkent 6
Guayaquil 5
Las Vegas 5
Pune 5
Querétaro 5
Vienna 5
Bari 4
Borås 4
Boston 4
Brussels 4
Duque de Caxias 4
Hangzhou 4
Hải Dương 4
Ipatinga 4
Jiaxing 4
Ribeirão Preto 4
Salvador 4
Wroclaw 4
Acalanes Ridge 3
Ahmedabad 3
Annapolis 3
Baghdad 3
Belford Roxo 3
Bogotá 3
Buffalo 3
Campinas 3
Canoas 3
Caracas 3
Casablanca 3
Totale 2.885
Salva come PNG Salva come JPEG
Nome #
Bladder cancer incidence rates and trends in young adults aged 20-39 years 255
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 183
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 173
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 137
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 134
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 128
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 127
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 126
Pulmonary lesion after surgery for renal cancer: progression or new primary? 124
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 124
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 123
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 122
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 122
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 120
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 119
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 118
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 113
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 111
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 111
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 110
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 109
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 103
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 101
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 97
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 96
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 95
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 92
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 91
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 90
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer 85
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 84
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer 84
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 82
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium 82
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 81
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 80
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 80
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study 79
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 77
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 72
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 69
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 66
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 65
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 64
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 62
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 62
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA 61
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 61
Erratum: Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010 (European urology oncology PII: S2588-9311(23)00237-7) 60
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 59
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 58
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 56
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder 54
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 53
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 53
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma 51
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy 50
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 50
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 48
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 48
Re: Stamatio Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920–9 47
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 47
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 47
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 47
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 46
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines 46
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 45
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 45
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 35
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 14
Re: Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 12
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathway 10
Acute kidney injury (AKI) and end stage kidney disease (ESKD) in CKD patients undergoing partial or radical nephrectomy for renal cancer: are we ready to unravel the uncertainty and create new hope? 9
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study 8
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer Patients 7
Totale 6.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202233 0 2 2 13 2 1 0 0 1 0 1 11
2022/2023358 131 84 35 5 6 42 6 29 15 0 1 4
2023/2024334 20 20 29 21 20 52 8 61 7 9 17 70
2024/20251.034 111 42 54 45 31 79 125 102 134 135 77 99
2025/20263.828 255 244 264 460 323 100 266 320 1.084 212 149 151
2026/2027423 151 272 0 0 0 0 0 0 0 0 0 0
Totale 6.055